Form 4: CME Group Director Daniel Kaye Acquires Shares Through Equity Plan

CME Group Inc. Director Daniel G. Kaye acquired 532 shares of Common Stock Class A on June 25, 2025, as part of the company's Director Stock Plan, increasing his total beneficial ownership to 4,200 shares.

Summary

• Daniel G. Kaye, a Director of CME Group Inc. (CME), reported an acquisition of company shares.
• On June 25, 2025, Mr. Kaye acquired 532 shares of Common Stock Class A.
• The shares were acquired at a price of $273.03 per share.
• This acquisition was granted pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this transaction, Daniel G. Kaye beneficially owns a total of 4,200 shares of Common Stock Class A.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if granted as part of a compensation plan, generally indicates alignment of interests with shareholders and confidence in the company's future, contributing to a moderately positive sentiment.

Positives

• Director Daniel G. Kaye increased his beneficial ownership in CME Group Inc. by acquiring 532 shares, aligning his interests further with shareholders.
• The acquisition was part of the CME Group Director Stock Plan, indicating a structured and routine approach to executive compensation and ownership.

Future Outlook

NA

Industry Context

This Form 4 filing details an insider transaction for CME Group Inc., a leading global markets company, and does not provide broader industry context beyond the company's specific equity compensation practices for its directors.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value due to increased equity ownership.

Key Dates

Recommendation

Keywords

CME Group, CME, Daniel G. Kaye, SEC Form 4, Insider Transaction, Stock Acquisition, Director Compensation, Equity Plan